People channel feed – Endpoints News

People channel feed

Struggling GSK recruits cancer drug guru Hal Barron as its new R&D chief

8 years ago

Feds charge Osiris execs with cooking the books as stock price soared

8 years ago

GSK R&D chief Vallance is out as its new CEO changes direction under a new crew

8 years ago

Shkreli out, Cuban in: Twitter proves essential for biotech rebel Ethan Perlstein

8 years ago

Grail CSO Vikram Bajaj jumps to VC firm Foresite, takes lead on personalized meds

8 years ago

Buzz: Will Brent Saunders split up Allergan if he loses the Restasis patent fight?

8 years ago

Biotech bad boy Martin Shkreli isn't getting his $5M in bail money back anytime soon

8 years ago

Peer Review: Eyeing a $350M venture fund, Nextech recruits Third Rock’s Jakob Loven for the team

8 years ago

Unicorn hunter Vivek Ramaswamy has cooked up a new deal with AstraZeneca. But what is it?

8 years ago

Sean Parker’s cancer institute keeps growing with some “mind blowing” new research projects

8 years ago

After jumping ship at Eli Lilly, Politico reports Alex Azar may soon land top HHS job

8 years ago

Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib

8 years ago

Former FDA chief von Eschenbach steps up his advisory role at Malin

8 years ago

With just a little encouragement, biotech investors are ready to fall in love again

8 years ago

Abbas Hussain swings from top GSK pharma post to powerhouse Chinese private equity player C-Bridge

8 years ago

Biotech scientist/entrepreneur Saurabh Saha makes an unusual return to the arms of a big — and excessively discreet — R&D group

8 years ago

Top scientists and BD execs craft Cullinan, a $150 million R&D portfolio shop focused on cancer

8 years ago

Sam Kulkarni takes the helm at CRISPR Therapeutics as founding CEO steps down

8 years ago

Genzyme vet David Meeker takes helm at stealthy KSQ with $76M and a new map for drug discovery

8 years ago

Eli Lilly R&D chief Jan Lundberg heads for the exit as CEO assembles a new team at the top

8 years ago

The $913M bonanza: Arie Belldegrun and his top team at Kite show you how to make a really rich deal

8 years ago

Small is big: Pharma’s R&D brain drain continues as GSK’s Chris Carpenter jumps to upstart Rubius

8 years ago

Pfizer spins off drug orphans into a PhIII-ready startup backed by Bain to the tune of $103M

8 years ago

Chris Garabedian's Xontogeny shepherds its first biotech through a $10M startup round

8 years ago

First page Previous page 91 92 939495 96 97 Next page Last page